Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
FOSFATO DIPOTASICO 1M FRESENIUS KABI 174,2 MG/ML SOLUCION INYECTABLE
Injection
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- FOSFATO POTASICO DIBASICO — 174.2 mg
- Pharmaceutical form Home Med Cabinet grouping
- Injection
- Availability in Spain
- All 2 packs marketed
Packs
FOSFATO DIPOTASICO 1M FRESENIUS KABI 174,2 MG/ML SOLUCION INYECTABLE , 100 ampollas de 10 ml
100 ampoules
National code
Marketed600215FOSFATO DIPOTASICO 1M FRESENIUS KABI 174,2 MG/ML SOLUCION INYECTABLE 10 ampollas de 10 ml
10 ampoules
National code
Marketed726519Strength of this pack 174.2 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 63546Official data
- Marketing authorisation holder
- FRESENIUS KABI ESPAÑA, S.A.U.Official data
- Authorised
- Dec 28, 2000Official data
- Authority form code
- 197Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.